Patents

Method for treating squamous intraepithelial lesions of the cervix uteri

The invention pertains to the field of medicine, more specifically to gynecology, and offers a novel method for treating squamous intraepithelial lesions of the cervix, regardless of their association with HPV. The invention facilitates the acceleration of epithelisation after performing destructive therapy for cervical intraepithelial neoplasia, and also reduces or eliminates the side effects.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Methd for colon cancer treatment

The invention pertains to medicine, more specifically to antitumor therapy, and can be used to treat the colon cancer. The antitumor drug L-lysine-alpha-oxidase from Trichoderma cf. aureoviride Rifai BKMF-4268D is used. It is administered five times daily in a total dose of 450-1000 E / kg, in equal parts, or administered five times at an interval of 48 hours at a total dose of 450 U / kg. The primary dose of the drug is 150 U / kg, and the rest of the drug is administered in equal doses. The proposed colon cancer treatment is more effective and less toxic.

T.T.Berezov E.V.Lukasheva E.M.Treschalina V.S.Pokrovsky A.Yu.Arinbasarov A.G.Medentsev A.Yu.Baryshnikov

Method of implanting the ureter into the urinary reservoir

The invention pertains to medicine, more specifically to surgery, and can be used to form ureteric-urorosurgical anastomoses after cystectomy, anterior and total pelvic eviscerations. In the prepared urinary reservoir the serous and muscular membranes are eliminated. The site is formed from the mucous membrane of the gut with a size of 3 × 1-2 cm. The distal section is made in the distal part with a length corresponding to the ureteral section. The continuous suture between the mucosa of the urinary reservoir and the stented ureter is applied. Anastomosis is covered with mobilized serous-muscle grafts. The grafts are fixed with nodal sutures. First, a suture is applied to the anterior wall of the ureter 0.5-1 cm from the anastomosis. The method makes it possible to simplify the technique of operation, to reduce the risk of postoperative insufficiency of anastomosis, vesicoureteral reflux, stenosis and stricture due to the imposing an anastomosis as a direct ureter-reservoir anastomosis and strengthening its valve mechanism.

A.V.Filimonyuk V.I.Kuznetsov M.B.Sharnov R.V.Tedoradze A.K.Antonov A.G.Strachuk

Capsule for pharmacological composition

The patent of the Republic of Belarus. This utility model pertains to the field of pharmacology, more specifically, to a capsule of a medicinal product and similar small volume vessels for oral pharmacological administration. The capsule has a cavity for placing a liquid pharmacological composition. The technical result of the utility model is the duration of the storage of the active component, since contact with the air is prevented, due to the high tightness of the lid and body connection, by the construction of the connecting elements and applied to them from the outside at the junction of the lid and body, along the entire length of the gelatine layer, remains unchanged and the appearance of the smell of the drug is excluded. The technical result is achieved by a capsule for a pharmacological composition consisting of the gelatine lid and body, inside which the medicinal product is located. According to the

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Monolithic suppository

The patent of the Republic of Belarus. The utility model pertains to the field of medicine, more specifically to the forms of immunomodulating medicinal drugs. The technical result of the utility model is the combination of high immunomodulating activity with a more effective design of the suppository form when inserting and fixing it in the body cavity. The claimed technical result is achieved due to the creating monolithic suppository consisting of active and auxiliary substances. According to the utility model, the upper part of the suppository is cone-shaped, and the lower part is cylinder-shaped.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Suppository device

Minor patent. The Republic of Tajikistan. The utility model pertains to the field of medicine, more specifically to the forms of immunomodulating medicinal drugs. The technical result of the utility model is the combination of high immunomodulating activity with a more effective design of the suppository form when inserting and fixing it in the body cavity. The claimed technical result is achieved due to the creating monolithic suppository consisting of active and auxiliary substances. According to the utility model, the upper part of the suppository is cone-shaped, and the lower part is cylinder-shaped.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Capsule for pharmacological composition

Minor patent. The Republic of Tajikistan. This utility model pertains to the field of pharmacology, more specifically, to a capsule of a medicinal product and similar small volume vessels for oral pharmacological administration. The capsule has a cavity for placing a liquid pharmacological composition. The technical result of the utility model is the duration of the storage of the active component, since contact with the air is prevented, due to the high tightness of the lid and body connection, by the construction of the connecting elements and applied to them from the outside at the junction of the lid and body, along the entire length of the gelatine layer, remains unchanged and the appearance of the smell of the drug is excluded. The technical result is achieved by a capsule for a pharmacological composition consisting of the gelatine lid and body, inside which the medicinal product is located. According to the utility model, the capsule through the entire line of the lid and body connection, is covered by the gelatine layer.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Capsule of a pharmaceutical composition

The patent of the Republic of Armenia. This utility model pertains to the field of pharmacology, more specifically, to a capsule of a medicinal product and similar small volume vessels for oral pharmacological administration. The capsule has a cavity for placing a liquid pharmacological composition. The technical result of the utility model is the duration of the storage of the active component, since contact with the air is prevented, due to the high tightness of the lid and body connection, by the construction of the connecting elements and applied to them from the outside at the junction of the lid and body, along the entire length of the gelatine layer, remains unchanged and the appearance of the smell of the drug is excluded. The technical result is achieved by a capsule for a pharmacological composition consisting of the gelatine lid and body, inside which the medicinal product is located. According to the utility model, the capsule through the entire line of the lid and body connection, is covered by the gelatine layer.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Sppository with immunomodulating activity

The patent of the Republic of Armenia. The utility model pertains to the field of medicine, more specifically to the forms of immunomodulating medicinal drugs. The technical result of the utility model is the combination of high immunomodulating activity with a more effective design of the suppository form when inserting and fixing it in the body cavity. The claimed technical result is achieved due to the creating monolithic suppository consisting of active and auxiliary substances. According to the utility model, the upper part of the suppository is cone-shaped, and the lower part is cylinder-shaped.

V.I.Kiselev V.M.Drukh I.N.Kuznetsov

Device for osteosynthesis and fixation of the sternum osteotomy

The utility model pertains to medicine, more specifically to traumatology. The use of the device allows preserving periosteal blood supply due to less trauma of the periosteum microcirculatory channel.

G.G.Batygin